Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 75
Selected: 0
NCT IDTitle
NCT04681079Comparison of Viral Particle Dispersion Following Administration of an MDI or Nebulizer in Subjects With COVID-19
NCT017044047 Days of TD-4208 in Subjects With Chronic Obstructive Pulmonary Disease
NCT01321879Study to Evaluate the Safety and Efficacy of Telavancin in the Treatment of Gram Positive Bloodstream Infections in Cancer Patients
NCT01333540A Study to Assess the Safety, Tolerability and Clinical Activity of TD-1211 in Patients With Opioid-Induced Constipation
NCT02705755TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH)
NCT03064113Effects of TD-4208 on FEV1 in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
NCT03829657Phase 3 Clinical Effect Durability of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure
NCT03573817A 42-day Parallel Group Safety Study of Revefenacin and Formoterol, Administered in Sequence and as a Combination, in Participants With COPD
NCT02663089A Phase 1 (Ph1), Single Dose (SD), GSK961081 Absorption, Distribution, Metabolism, and Excretion (ADME) Study in Healthy Subjects
NCT03750552Clinical Effect of Ampreloxetine (TD-9855) for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure
NCT02267525The Diabetic and Idiopathic Gastroparesis Efficacy, Safety, and Tolerability (DIGEST) Study
NCT02753855Pharmacokinetics of Telavancin in Normal and Obese Subjects
NCT00674817An Investigation Of The Interaction Of GSK961081 With Inhaled Beta-Agonist And Anti-Muscarinic Drugs.
NCT01655771TD-1211 Single-Dose Study in Elderly and Young Healthy Subjects
NCT01568411A Fixed-Sequence, Two-Period, Open-Label Drug-Drug Interaction Study to Assess the Effect of an Inhibitor of Cytochrome P450 Isoenzyme 3A4 and Permeability Glycoprotein 1 on the Pharmacokinetics of TD-1211
NCT02903095Single Ascending Dose Study of TD-1439 in Healthy Subjects
NCT02818686TD-1473 for Active Ulcerative Colitis (UC)
NCT02040792A 28-Day Parallel Group Study of TD-4208 in Chronic Obstructive Pulmonary Disease (COPD)
NCT01467726Safety, Pharmacokinetics and Pharmacodynamics of Velusetrag in Healthy Elderly Subjects
NCT01924143TD-9855 Mass Balance Study
NCT04095793Phase 3 Open-Label Extension Study of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure
NCT04315558Revefenacin in Acute Respiratory Insufficiency in COPD
NCT07816835Nebulizer Versus Handheld Maintenance Therapy for Patients With COPD
NCT01693692Phase 2 Study of TD-9855 to Treat Fibromyalgia
NCT04688632Thorough QT Study to Evaluate Ampreloxetine in Healthy Subjects
NCT01401985A Study of TD-1211 in Subjects With Opioid-Induced Constipation (OIC)
NCT03555617Food-effect, Drug-Drug Interaction (DDI), and Formulation Bridging Study
NCT00887406Study of GSK961081 in Healthy Volunteer Subjects
NCT04044339Single and Multiple Ascending Dose, First-in- Human Study in Healthy Subjects
NCT02581592Pharmacokinetics of TD-4208 in Patients With Moderate Hepatic Impairment
NCT01040637A Multiple Dose Study of TD-1211 in Healthy Volunteers and Patients With Opioid-Induced Constipation
NCT03920254TD-1473 Long-Term Safety (LTS) Ulcerative Colitis (UC) Study
NCT00391820Evaluate the Safety and Efficacy of a 5-HT4 Agonist in Chronic Constipation (ACCORD Trial)
NCT05091723TD-0903 Pharmacokinetics Study in Healthy Participants With Supplemental Oxygenation
NCT02820311Thorough QT (TQT) Study of TD-4208 in Healthy Subjects
NCT04350736First in Human SAD and MAD Study of Inhaled TD-0903, a Potential Treatment for ALI Associated With COVID-19
NCT03103412TD-3504 SAD in Healthy Subjects and Subjects With Ulcerative Colitis (UC)
NCT04150341Effect of Inhaled TD-8236 on Allergen-induced Asthmatic Response
NCT04402866TD-0903 for ALI Associated With COVID-19
NCT04587713Single Dose Bioavailability and Ethnobridging PK Study in Healthy Subjects
NCT07133880Compare the Effects of Nebulizer Versus Inhaler Based Therapy for COPD Using Long-acting Bronchodilators
NCT05165485Phase 4 COPD and Suboptimal Inspiratory Flow Rate
NCT05696717Phase 3 Efficacy and Durability of Ampreloxetine for the Treatment of Symptomatic nOH in Participants With Multiple System Atrophy
NCT02512510Efficacy Study of Nebulized TD-4208 for Chronic Obstructive Pulmonary Disease (COPD)
NCT03408470TD-1473 Absorption, Distribution, Metabolism and Excretion (ADME) Study in Healthy Male Subjects
NCT04200573Effect of Hepatic Impairment on the Pharmacokinetics of a Single Dose of TD-9855
NCT01953081A Randomized, Double-Blind Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of a Single Dose of Intravenous TD-8954 Compared With Metoclopramide in Critically Ill Patients With Enteral Feeding Intolerance
NCT02772159TD-4208 Absorption, Distribution, Metabolism and Excretion (ADME) Study in Healthy Male Subjects
NCT00550225Succinate Salt Version of GSK961081 for Healthy Volunteers
NCT00687700A Study to Investigate the Pharmacology of a Dual Pharmacophore in Healthy Volunteers